Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors.

Hagenbeek TJ, Webster JD, Kljavin NM, Chang MT, Pham T, Lee HJ, Klijn C, Cai AG, Totpal K, Ravishankar B, Yang N, Lee DH, Walsh KB, Hatzivassiliou G, de la Cruz CC, Gould SE, Wu X, Lee WP, Yang S, Zhang Z, Gu Q, Ji Q, Jackson EL, Lim DS, Dey A.

Sci Signal. 2018 Sep 11;11(547). pii: eaaj1757. doi: 10.1126/scisignal.aaj1757.

PMID:
30206136
2.

A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC.

Dompe N, Klijn C, Watson SA, Leng K, Port J, Cuellar T, Watanabe C, Haley B, Neve R, Evangelista M, Stokoe D.

PLoS One. 2018 Jun 18;13(6):e0199264. doi: 10.1371/journal.pone.0199264. eCollection 2018.

3.

A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.

Wagle MC, Kirouac D, Klijn C, Liu B, Mahajan S, Junttila M, Moffat J, Merchant M, Huw L, Wongchenko M, Okrah K, Srinivasan S, Mounir Z, Sumiyoshi T, Haverty PM, Yauch RL, Yan Y, Kabbarah O, Hampton G, Amler L, Ramanujan S, Lackner MR, Huang SA.

NPJ Precis Oncol. 2018 Mar 7;2(1):7. doi: 10.1038/s41698-018-0051-4. eCollection 2018.

4.

Perprocedural aneurysm rerupture in relation to timing of endovascular treatment and outcome.

van Lieshout JH, Verbaan D, Donders R, van den Berg R, Vandertop PWP, Klijn CJM, Steiger HJ, de Vries J, Bartels RHMA, Beseoglu K, Boogaarts HD.

J Neurol Neurosurg Psychiatry. 2018 May 31. pii: jnnp-2018-318090. doi: 10.1136/jnnp-2018-318090. [Epub ahead of print] No abstract available.

PMID:
29853533
5.

Cerebral small vessel disease: from a focal to a global perspective.

Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE.

Nat Rev Neurol. 2018 Jul;14(7):387-398. doi: 10.1038/s41582-018-0014-y. Review.

PMID:
29802354
6.

Effect of Antihypertensive Medication on Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.

van Middelaar T, Argillander TE, Schreuder FHBM, Deinum J, Richard E, Klijn CJM.

Stroke. 2018 Jun;49(6):1531-1533. doi: 10.1161/STROKEAHA.118.021160. Epub 2018 May 8.

PMID:
29739911
7.

Predicting the presence of macrovascular causes in non-traumatic intracerebral haemorrhage: the DIAGRAM prediction score.

Hilkens NA, van Asch CJJ, Werring DJ, Wilson D, Rinkel GJE, Algra A, Velthuis BK, de Kort GAP, Witkamp TD, van Nieuwenhuizen KM, de Leeuw FE, Schonewille WJ, de Kort PLM, Dippel DWJ, Raaymakers TWM, Hofmeijer J, Wermer MJH, Kerkhoff H, Jellema K, Bronner IM, Remmers MJM, Bienfait HP, Witjes RJGM, Jäger HR, Greving JP, Klijn CJM; DIAGRAM study group.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):674-679. doi: 10.1136/jnnp-2017-317262. Epub 2018 Jan 18.

PMID:
29348301
8.

Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.

Ikink GJ, Boer M, Bakker ERM, Vendel-Zwaagstra A, Klijn C, Ten Hoeve J, Jonkers J, Wessels LF, Hilkens J.

Oncogene. 2018 Mar;37(12):1594-1609. doi: 10.1038/s41388-017-0031-0. Epub 2018 Jan 12.

PMID:
29326437
9.

SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.

Viotti M, Wilson C, McCleland M, Koeppen H, Haley B, Jhunjhunwala S, Klijn C, Modrusan Z, Arnott D, Classon M, Stephan JP, Mellman I.

J Cell Biol. 2018 Feb 5;217(2):763-777. doi: 10.1083/jcb.201705031. Epub 2017 Dec 11.

10.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27.

PMID:
29076399
11.

USP7 small-molecule inhibitors interfere with ubiquitin binding.

Kategaya L, Di Lello P, Rougé L, Pastor R, Clark KR, Drummond J, Kleinheinz T, Lin E, Upton JP, Prakash S, Heideker J, McCleland M, Ritorto MS, Alessi DR, Trost M, Bainbridge TW, Kwok MCM, Ma TP, Stiffler Z, Brasher B, Tang Y, Jaishankar P, Hearn BR, Renslo AR, Arkin MR, Cohen F, Yu K, Peale F, Gnad F, Chang MT, Klijn C, Blackwood E, Martin SE, Forrest WF, Ernst JA, Ndubaku C, Wang X, Beresini MH, Tsui V, Schwerdtfeger C, Blake RA, Murray J, Maurer T, Wertz IE.

Nature. 2017 Oct 26;550(7677):534-538. doi: 10.1038/nature24006. Epub 2017 Oct 18.

PMID:
29045385
12.

Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.

Behrouz R, Masjuán-Vallejo J, Vera R, Willey JZ, Zedet M, Moulin S, Cordonnier C, Klijn CJM, Kanselaar K, Dirks M, Silver B, Khan M, Azarpazhooh MR, Godoy DA, Roffe C, Paley L, Bray BD, Smith CJ, Di Napoli M; ITAS-90+ Collaborative.

J Stroke Cerebrovasc Dis. 2018 Jan;27(1):246-256. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.031. Epub 2017 Sep 19.

PMID:
28935502
13.

Functional impairments for outcomes in a randomized trial of unruptured brain AVMs.

Mohr JP, Overbey JR, von Kummer R, Stefani MA, Libman R, Stapf C, Parides MK, Pile-Spellman J, Moquete E, Moy CS, Vicaut E, Moskowitz AJ, Harkness K, Cordonnier C, Biondi A, Houdart E, Berkefeld J, Klijn CJM, Barreau X, Kim H, Hartmann A; International ARUBA Investigators.

Neurology. 2017 Oct 3;89(14):1499-1506. doi: 10.1212/WNL.0000000000004532. Epub 2017 Sep 6.

PMID:
28878048
14.

Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.

van Leijsen EMC, van Uden IWM, Ghafoorian M, Bergkamp MI, Lohner V, Kooijmans ECM, van der Holst HM, Tuladhar AM, Norris DG, van Dijk EJ, Rutten-Jacobs LCA, Platel B, Klijn CJM, de Leeuw FE.

Neurology. 2017 Oct 10;89(15):1569-1577. doi: 10.1212/WNL.0000000000004490. Epub 2017 Sep 6.

15.

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches.

Foster SA, Klijn C, Malek S.

Trends Cancer. 2016 Dec;2(12):699-701. doi: 10.1016/j.trecan.2016.10.015. Epub 2016 Nov 21.

PMID:
28741516
16.

Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.

Kas SM, de Ruiter JR, Schipper K, Annunziato S, Schut E, Klarenbeek S, Drenth AP, van der Burg E, Klijn C, Ten Hoeve JJ, Adams DJ, Koudijs MJ, Wesseling J, Nethe M, Wessels LFA, Jonkers J.

Nat Genet. 2017 Aug;49(8):1219-1230. doi: 10.1038/ng.3905. Epub 2017 Jun 26.

PMID:
28650484
17.

Relative risk of hemorrhage during pregnancy in patients with brain arteriovenous malformations.

van Beijnum J, Wilkinson T, Whitaker HJ, van der Bom JG, Algra A, Vandertop WP, van den Berg R, Brouwer PA, Rinkel GJ, Kappelle LJ, Al-Shahi Salman R; Scottish Audit of Intracranial Vascular Malformations collaborators, Klijn CJ.

Int J Stroke. 2017 Oct;12(7):741-747. doi: 10.1177/1747493017694387. Epub 2017 Feb 27.

PMID:
28635373
18.

Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage.

Di Napoli M, Behrouz R, Topel CH, Misra V, Pomero F, Giraudo A, Pennati P, Masotti L, Schreuder FHBM, Staals J, Klijn CJM, Smith CJ, Parry-Jones AR, Slevin MA, Silver B, Willey JZ, Azarpazhooh MR, Vallejo JM, Nzwalo H, Popa-Wagner A, Godoy DA; MNEMONICH Investigators.

J Crit Care. 2017 Oct;41:247-253. doi: 10.1016/j.jcrc.2017.06.002. Epub 2017 Jun 1.

PMID:
28599198
19.

In patients with intracerebral haemorrhage and concomitant atrial fibrillation, optimal timing of reinitiating anticoagulants may be 7-8 weeks after ICH.

Klijn CJ, Schreuder FH.

Evid Based Med. 2017 Jun;22(3):108-109. doi: 10.1136/ebmed-2017-110675. Epub 2017 May 16. No abstract available.

PMID:
28512110
20.

Age-Specific Vascular Risk Factor Profiles According to Stroke Subtype.

Hauer AJ, Ruigrok YM, Algra A, van Dijk EJ, Koudstaal PJ, Luijckx GJ, Nederkoorn PJ, van Oostenbrugge RJ, Visser MC, Wermer MJ, Kappelle LJ, Klijn CJM; Dutch Parelsnoer Institute‐Cerebrovascular Accident Study Group.

J Am Heart Assoc. 2017 May 8;6(5). pii: e005090. doi: 10.1161/JAHA.116.005090.

21.

New microbleed after blood-brain barrier leakage in intracerebral haemorrhage.

van Nieuwenhuizen KM, Hendrikse J, Klijn CJM.

BMJ Case Rep. 2017 Apr 27;2017. pii: bcr-2016-218794. doi: 10.1136/bcr-2016-218794.

PMID:
28450470
22.

Clinical Course and Outcomes of Small Supratentorial Intracerebral Hematomas.

Behrouz R, Misra V, Godoy DA, Topel CH, Masotti L, Klijn CJM, Smith CJ, Parry-Jones AR, Slevin MA, Silver B, Willey JZ, Masjuán Vallejo J, Nzwalo H, Popa-Wagner A, Malek AR, Hafeez S, Di Napoli M; MNEMONICH Investigators.

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1216-1221. doi: 10.1016/j.jstrokecerebrovasdis.2017.01.010. Epub 2017 Feb 3.

PMID:
28169096
23.

Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells.

Lee HJ, Cao Y, Pham V, Blackwood E, Wilson C, Evangelista M, Klijn C, Stokoe D, Settleman J.

Mol Cancer Ther. 2017 Apr;16(4):694-704. doi: 10.1158/1535-7163.MCT-16-0504. Epub 2017 Jan 30.

24.

[Ischemic stroke in young women].

Ekker MS, Wermer MJ, Riksen NP, Klijn CJ, de Leeuw FE.

Ned Tijdschr Geneeskd. 2016;160:D689. Review. Dutch.

PMID:
27966404
25.

Blood pressure levels and the risk of intracerebral hemorrhage after ischemic stroke.

Hilkens NA, Greving JP, Algra A, Klijn CJ.

Neurology. 2017 Jan 10;88(2):177-181. doi: 10.1212/WNL.0000000000003489. Epub 2016 Dec 7.

PMID:
27927936
26.

Medical management of intracerebral haemorrhage.

Schreuder FH, Sato S, Klijn CJ, Anderson CS.

J Neurol Neurosurg Psychiatry. 2017 Jan;88(1):76-84. doi: 10.1136/jnnp-2016-314386. Epub 2016 Nov 16. Review.

PMID:
27852691
27.

Female- and Male-Specific Risk Factors for Stroke: A Systematic Review and Meta-analysis.

Poorthuis MH, Algra AM, Algra A, Kappelle LJ, Klijn CJ.

JAMA Neurol. 2017 Jan 1;74(1):75-81. doi: 10.1001/jamaneurol.2016.3482. Review.

PMID:
27842176
28.

Genetic variants in CETP increase risk of intracerebral hemorrhage.

Anderson CD, Falcone GJ, Phuah CL, Radmanesh F, Brouwers HB, Battey TW, Biffi A, Peloso GM, Liu DJ, Ayres AM, Goldstein JN, Viswanathan A, Greenberg SM, Selim M, Meschia JF, Brown DL, Worrall BB, Silliman SL, Tirschwell DL, Flaherty ML, Kraft P, Jagiella JM, Schmidt H, Hansen BM, Jimenez-Conde J, Giralt-Steinhauer E, Elosua R, Cuadrado-Godia E, Soriano C, van Nieuwenhuizen KM, Klijn CJ, Rannikmae K, Samarasekera N, Al-Shahi Salman R, Sudlow CL, Deary IJ, Morotti A, Pezzini A, Pera J, Urbanik A, Pichler A, Enzinger C, Norrving B, Montaner J, Fernandez-Cadenas I, Delgado P, Roquer J, Lindgren A, Slowik A, Schmidt R, Kidwell CS, Kittner SJ, Waddy SP, Langefeld CD, Abecasis G, Willer CJ, Kathiresan S, Woo D, Rosand J; Global Lipids Genetics Consortium and International Stroke Genetics Consortium.

Ann Neurol. 2016 Nov;80(5):730-740. doi: 10.1002/ana.24780. Epub 2016 Oct 19.

29.

Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers.

Goldstein LD, Lee J, Gnad F, Klijn C, Schaub A, Reeder J, Daemen A, Bakalarski CE, Holcomb T, Shames DS, Hartmaier RJ, Chmielecki J, Seshagiri S, Gentleman R, Stokoe D.

Cell Rep. 2016 Sep 6;16(10):2605-2617. doi: 10.1016/j.celrep.2016.08.010. Epub 2016 Aug 25.

30.

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

Drost R, Dhillon KK, van der Gulden H, van der Heijden I, Brandsma I, Cruz C, Chondronasiou D, Castroviejo-Bermejo M, Boon U, Schut E, van der Burg E, Wientjens E, Pieterse M, Klijn C, Klarenbeek S, Loayza-Puch F, Elkon R, van Deemter L, Rottenberg S, van de Ven M, Dekkers DH, Demmers JA, van Gent DC, Agami R, Balmaña J, Serra V, Taniguchi T, Bouwman P, Jonkers J.

J Clin Invest. 2016 Aug 1;126(8):2903-18. doi: 10.1172/JCI70196. Epub 2016 Jul 25.

31.

The forecast for future clinical trials and clinical trialists-Storms or sunshine?

Klijn CJ, Sandercock PA.

Int J Stroke. 2016 Oct;11(7):738-40. doi: 10.1177/1747493016655362. Epub 2016 Jun 17.

PMID:
27316456
32.

Parental age and the occurrence of sporadic brain arteriovenous malformations.

Hauer AJ, van Beijnum J, Vandertop WP, van den Berg R, Brouwer PA, Kappelle LJ, Ruigrok YM, Klijn CJ.

Int J Stroke. 2016 Oct;11(8):NP89-NP90. doi: 10.1177/1747493016654339. Epub 2016 Jul 9. No abstract available. Erratum in: Int J Stroke. 2018 Jun;13(4):NP8.

PMID:
27312680
33.

Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy.

van Veluw SJ, Biessels GJ, Klijn CJ, Rozemuller AJ.

Neurology. 2016 Mar 1;86(9):867-71. doi: 10.1212/WNL.0000000000002419. Epub 2016 Feb 3.

PMID:
26843561
34.

Genome-wide association study of sporadic brain arteriovenous malformations.

Weinsheimer S, Bendjilali N, Nelson J, Guo DE, Zaroff JG, Sidney S, McCulloch CE, Al-Shahi Salman R, Berg JN, Koeleman BP, Simon M, Bostroem A, Fontanella M, Sturiale CL, Pola R, Puca A, Lawton MT, Young WL, Pawlikowska L, Klijn CJ, Kim H; GEN-AVM Consortium.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):916-23. doi: 10.1136/jnnp-2015-312272. Epub 2016 Jan 27.

35.

Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.

Bersano A, Guey S, Bedini G, Nava S, Hervé D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; European Moyamoya Disease Initiative.

Cerebrovasc Dis. 2016;41(3-4):105-18. doi: 10.1159/000442298. Epub 2016 Jan 12. Review.

36.

Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study.

van Asch CJ, Velthuis BK, Rinkel GJ, Algra A, de Kort GA, Witkamp TD, de Ridder JC, van Nieuwenhuizen KM, de Leeuw FE, Schonewille WJ, de Kort PL, Dippel DW, Raaymakers TW, Hofmeijer J, Wermer MJ, Kerkhoff H, Jellema K, Bronner IM, Remmers MJ, Bienfait HP, Witjes RJ, Greving JP, Klijn CJ; DIAGRAM Investigators.

BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.

37.

Intracerebral haemorrhage, atrial fibrillation, and anticoagulation.

Wilson D, Al-Shahi Salman R, Klijn CJ, Lip GY, Werring DJ.

Lancet. 2015 Oct 31;386(10005):1736-7. doi: 10.1016/S0140-6736(15)00695-9. No abstract available.

PMID:
26545435
38.

Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease.

Kremer PH, Jolink WM, Kappelle LJ, Algra A, Klijn CJ; SMART and ESPRIT Study Groups.

PLoS One. 2015 Nov 5;10(11):e0142338. doi: 10.1371/journal.pone.0142338. eCollection 2015.

39.

Outcome after intracranial haemorrhage from dural arteriovenous fistulae; a systematic review and case-series.

Jolink WM, van Dijk JM, van Asch CJ, de Kort GA, Algra A, Groen RJ, Rinkel GJ, Klijn CJ.

J Neurol. 2015 Dec;262(12):2678-83. doi: 10.1007/s00415-015-7898-x. Epub 2015 Sep 26. Review.

40.

Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage.

Jolink WM, Klijn CJ, Brouwers PJ, Kappelle LJ, Vaartjes I.

Neurology. 2015 Oct 13;85(15):1318-24. doi: 10.1212/WNL.0000000000002015. Epub 2015 Sep 16.

PMID:
26377254
41.

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ; APACHE-AF Investigators.

Trials. 2015 Sep 4;16:393. doi: 10.1186/s13063-015-0898-4.

42.

Susceptibility loci for sporadic brain arteriovenous malformation; a replication study and meta-analysis.

Kremer PH, Koeleman BP, Rinkel GJ, Diekstra FP, van den Berg LH, Veldink JH, Klijn CJ.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):693-6. doi: 10.1136/jnnp-2014-310094. Epub 2015 Aug 13.

PMID:
26272027
43.

Cortical microinfarcts on 7 T MRI in patients with spontaneous intracerebral hemorrhage.

van Veluw SJ, Jolink WM, Hendrikse J, Geerlings MI, Luijten PR, Biessels GJ, Klijn CJ.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1222. doi: 10.1038/jcbfm.2015.34. No abstract available.

44.

Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis.

Hofmeijer J, Kappelle LJ, Klijn CJ.

Pract Neurol. 2015 Aug;15(4):250-6. doi: 10.1136/practneurol-2015-001104. Epub 2015 Apr 28. Review.

PMID:
25922539
45.

A resource for cell line authentication, annotation and quality control.

Yu M, Selvaraj SK, Liang-Chu MM, Aghajani S, Busse M, Yuan J, Lee G, Peale F, Klijn C, Bourgon R, Kaminker JS, Neve RM.

Nature. 2015 Apr 16;520(7547):307-11. doi: 10.1038/nature14397.

PMID:
25877200
46.

[Resumption of antithrombotic treatment after an intracerebral haemorrhage].

Kappelle LJ, Hofmeijer J, Chamuleau SA, van Nieuwenhuizen KM, Hemels ME, Klijn CJ.

Ned Tijdschr Geneeskd. 2015;159:A8507. Review. Dutch.

PMID:
25873219
47.

Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.

Parry-Jones AR, Di Napoli M, Goldstein JN, Schreuder FH, Tetri S, Tatlisumak T, Yan B, van Nieuwenhuizen KM, Dequatre-Ponchelle N, Lee-Archer M, Horstmann S, Wilson D, Pomero F, Masotti L, Lerpiniere C, Godoy DA, Cohen AS, Houben R, Al-Shahi Salman R, Pennati P, Fenoglio L, Werring D, Veltkamp R, Wood E, Dewey HM, Cordonnier C, Klijn CJ, Meligeni F, Davis SM, Huhtakangas J, Staals J, Rosand J, Meretoja A.

Ann Neurol. 2015 Jul;78(1):54-62. doi: 10.1002/ana.24416. Epub 2015 May 14.

48.

"STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy.

Esposito G, Kronenburg A, Fierstra J, Braun KP, Klijn CJ, van der Zwan A, Regli L.

Childs Nerv Syst. 2015 May;31(5):765-72. doi: 10.1007/s00381-015-2665-y. Epub 2015 Feb 27.

49.

Calibrated MRI to evaluate cerebral hemodynamics in patients with an internal carotid artery occlusion.

De Vis JB, Petersen ET, Bhogal A, Hartkamp NS, Klijn CJ, Kappelle LJ, Hendrikse J.

J Cereb Blood Flow Metab. 2015 Jun;35(6):1015-23. doi: 10.1038/jcbfm.2015.14. Epub 2015 Feb 25.

50.

A comprehensive transcriptional portrait of human cancer cell lines.

Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H, Degenhardt J, Mayba O, Gnad F, Liu J, Pau G, Reeder J, Cao Y, Mukhyala K, Selvaraj SK, Yu M, Zynda GJ, Brauer MJ, Wu TD, Gentleman RC, Manning G, Yauch RL, Bourgon R, Stokoe D, Modrusan Z, Neve RM, de Sauvage FJ, Settleman J, Seshagiri S, Zhang Z.

Nat Biotechnol. 2015 Mar;33(3):306-12. doi: 10.1038/nbt.3080. Epub 2014 Dec 8.

PMID:
25485619

Supplemental Content

Support Center